{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:12:42Z","timestamp":1790039562480,"version":"4.0.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1093\/ndt\/gft515","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T22:23:56Z","timestamp":1389133436000},"page":"672-681","source":"Crossref","is-referenced-by-count":210,"title":["Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial"],"prefix":"10.1093","volume":"29","author":[{"given":"Rajiv","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun D.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri N.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew G.","family":"Tegegne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,6]]},"reference":[{"key":"key\n\t\t\t\t20170515175843_GFT515C1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","article-title":"Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States","volume":"115","author":"Agarwal","year":"2003","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170515175843_GFT515C2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1523-1755.1998.00853.x","article-title":"Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients","volume":"53","author":"Zoccali","year":"1998","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175843_GFT515C3","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/ki.1997.254","article-title":"Influence of nycthemeral blood pressure pattern in treated hypertensive patients on hemodialysis","volume":"51","author":"Amar","year":"1997","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175843_GFT515C4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/HYPERTENSIONAHA.110.154815","article-title":"Hypervolemia is associated with increased mortality among hemodialysis patients","volume":"56","author":"Agarwal","year":"2010","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515175843_GFT515C5","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.108.125674","article-title":"Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial","volume":"53","author":"Agarwal","year":"2009","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515175843_GFT515C6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.0894-0959.2004.17324.x","article-title":"Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications","volume":"17","author":"Blankestijn","year":"2004","journal-title":"Semin Dial"},{"key":"key\n\t\t\t\t20170515175843_GFT515C7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(09)60212-9","article-title":"Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials","volume":"373","author":"Heerspink","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515175843_GFT515C8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/HYPERTENSIONAHA.108.128116","article-title":"Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis","volume":"53","author":"Agarwal","year":"2009","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515175843_GFT515C9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515175843_GFT515C10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170515175843_GFT515C11","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1046\/j.1523-1755.1999.00359.x","article-title":"Supervised atenolol therapy in the management of hemodialysis hypertension","volume":"55","author":"Agarwal","year":"1999","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175843_GFT515C12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1053\/ajkd.2001.29221","article-title":"Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses","volume":"38","author":"Agarwal","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515175843_GFT515C13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/j.ajkd.2006.07.005","article-title":"The epidemiology of systolic blood pressure and death risk in hemodialysis patients","volume":"48","author":"Li","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515175843_GFT515C14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.HYP.0000154895.18269.67","article-title":"Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions","volume":"45","author":"Kalantar-Zadeh","year":"2005","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515175843_GFT515C15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","article-title":"Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies","volume":"70","author":"Zannad","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175843_GFT515C16","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515175843_GFT515C17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJM199507203330304","article-title":"Attenuation of isoproterenol-mediated vasodilatation in blacks","volume":"333","author":"Lang","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515175843_GFT515C18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.HYP.36.6.945","article-title":"Increased vascular adrenergic vasoconstriction and decreased vasodilation in blacks. Additive mechanisms leading to enhanced vascular reactivity","volume":"36","author":"Stein","year":"2000","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515175843_GFT515C19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.HYP.31.5.1088","article-title":"Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives","volume":"31","author":"Weir","year":"1998","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515175843_GFT515C20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.HYP.1.2.136","article-title":"Racial differences in pressure, volume and renin interrelationships in essential hypertension","volume":"1","author":"Chrysant","year":"1979","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515175843_GFT515C21","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","article-title":"Sympathetic overactivity in patients with chronic renal failure","volume":"327","author":"Converse","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515175843_GFT515C22","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/hc1102.105261","article-title":"Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease","volume":"105","author":"Zoccali","year":"2002","journal-title":"Circulation"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/29\/3\/672\/17109027\/gft515.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T01:56:31Z","timestamp":1503539791000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gft515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,6]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,1,6]]},"published-print":{"date-parts":[[2014,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gft515","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718231059.793497601","asserted-by":"object"}]},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,6]]}}}